Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia
Biology of Blood and Marrow Transplantation, 08/03/2012
Buchbinder D et al. – The results indicated that all patients undergoing hematopoietic cell transplantation (HCT) for severe aplastic anemia (SAA) remain at–risk for late effects and must be counseled about and should be monitored for late effects for the remainder of their lives.



